Search Videos and More
Miami Cancer Institute Launches Global Consortium to Speed and Improve Bladder Cancer Care Worldwide
Miami Cancer Institute has spearheaded the creation of the Global Bladder Cancer Consortium (GBCC), a collaboration between the world’s top experts in bladder cancer. Among the GBCC’s priorities are creating a large and diverse patient database, launching clinical trials at multiple sites throughout the world and sharing information - all initiatives that will impact patient outcomes and improve care for those with bladder cancer.Subspecialized GI Oncologists of Benefit to Patients with GI Cancers
Gastrointestinal (GI) cancers are among the deadliest cancer diagnoses, yet not all patients with GI cancers will see a subspecialist. Considering the explosive pace at which cancer care is changing ? with the development of new medications, increasingly sophisticated treatments and the availability of clinical trials ? most patients with GI cancers would significantly benefit from seeing a gastrointestinal oncologist, says Gretel Terrero, M.D., a triple board-certified hematologist and medical oncologist at Baptist Health’s Miami Cancer Institute who subspecializes in GI cancers.Miami Cancer Institute First in World to Deliver Adaptive MR-Guided Radiation Therapy with the MRIdian® A3i System
At Miami Cancer Institute, part of Baptist Health South Florida, a Miami woman is now the first pancreas cancer patient in the world to be treated using an advanced platform for adaptive MR-guided radiotherapy.Baptist Health Acquires Sophisticated New Platform for Brain Tumor Treatment
Always seeking to further the level of care available to cancer patients in the region, Baptist Health South Florida has added a sophisticated new radiosurgery platform to its arsenal of cancer-fighting technology.Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment Survival
When Gwen Watson was diagnosed with glioblastoma (GBM), an aggressive brain cancer, she and her husband didn’t hesitate to drive four and a half hours from their home in DeLand, Florida, to Baptist Health’s Miami Cancer Institute so that she could receive state-of-the art multi-disciplinary care and enroll in a clinical trial.Miami Cancer Institute Physicians Were in the Spotlight at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Physician researchers from the Miami Cancer Institute presented the latest advances and information on new clinical trials from novel therapies to inhibit tumor proliferation and stimulate anti-cancer responses in patients with advanced solid tumors.The Debrief with Dr. Zinner featuring guest Guenther Koehne, M.D., Ph.D.
Join Dr. Zinner., CEO and Executive Medical Director at Miami Cancer Institute and Dr. Koehne, Deputy Director and Chief of Blood & Marrow Transplant, Hematologic Oncology and Benign Hematology, on the first episode of The Debrief as they discuss some of the latest advancements in hematology.Miami Cancer Institute Takes Action To Address Inequities in Cancer Care with Expanded COTA, Inc. Collaboration
Miami Cancer Institute, part of Baptist Health South Florida, will leverage COTA’s Real-World Analytics to drive standardization of care across all cancer patientsStudy by Miami Cancer Institute Physician Researchers Promises to Change Way Metastatic Brain Cancer is Treated
For patients with cancer that has metastasized to the brain, the standard treatment for years has been to resect, or surgically remove, the lesion and follow that with radiation therapy (RT) to the whole brain, which prevents relapse by destroying any remaining cancer cells.Baptist Health’s Miami Cancer Institute named as 2022 Recipient of Warren E. Weaver/Richard P. Penna Award
The Board of Pharmacy Specialties (BPS) is pleased to announce the two Warren E. Weaver/Richard P. Penna award winners in the patient care organization and individual category. Baptist Health’s Miami Cancer Institute Pharmacy Program in Miami, FL has been named the 2022 recipient of the Warren E. Weaver/Richard P. Penna Award in the organization category.Beating the Odds: Pancreatic Cancer Survivor is Living Life to the Fullest
At the start of 2019, Bob Dickinson got a diagnosis no one wants - pancreatic cancer. Until very recently, pancreatic cancer cases rarely have had a happy ending, with a traditionally quoted survival rate of just 10 percent. But Mr. Dickinson says he was determined to “make lemonade out of lemons” and was prepared to travel anywhere in the country for the best care.New Advances in the Management of Pancreatic Cancer
Originally Broadcast: November 9, 2021. Dr. Horacio Asbun, Dr. Michael Chuong, Dr. Ripal Gandhi and Dr. Govindarajan Narayanan examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care.